El Salvador vs North Korea: Treatment success rate for patients treated for MDR-TB
El Salvador
80.0%
in 2022
North Korea
80.0%
in 2022
El Salvador rank
50th
North Korea rank
50th
Treatment success rate for patients treated for MDR-TB over time
- El Salvador
- North Korea
How they compare
El Salvador currently reports 80.0% against 80.0% in North Korea, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2012 it was El Salvador ahead.
El Salvador ranks 50th and North Korea ranks 50th of 163 countries.
El Salvador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | El Salvador | North Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.0% | 79.9% | 11.1% | El Salvador |
| 2020s | 86.3% | 76.7% | 9.7% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, El Salvador or North Korea?
- El Salvador, at 80.0% against 80.0% in North Korea as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between El Salvador and North Korea?
- 0.0%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and North Korea?
- 11 years are reported by both, from 2012 to 2022.
- How do El Salvador and North Korea rank globally for treatment success rate for patients treated for mdr-tb?
- El Salvador ranks 50th and North Korea ranks 50th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.